Literature DB >> 16549332

Venous resection in pancreatic cancer surgery.

Jennifer F Tseng1, Eric P Tamm, Jeffrey E Lee, Peter W T Pisters, Douglas B Evans.   

Abstract

Vascular resection and reconstruction at the time of pancreaticoduodenectomy (PD) adds complexity to an already demanding operation. In this chapter, we review the indications, surgical techniques, and most recent results of venous resection combined with PD. The need for venous resection may not always be apparent on preoperative imaging, and surgeons who perform PD should be familiar with standard techniques necessary for vascular resection and reconstruction. Recent data suggest that with proper patient selection and surgeon experience, vascular resection and reconstruction can be performed safely and does not impact survival duration even in patients with pancreatic ductal adenocarcinoma. The median survival of patients who underwent PD and required vascular resection was 23 months, approximately 1 year longer than the survival of patients with locally advanced, surgically unresectable pancreatic cancer who receive palliative chemotherapy or chemoradiation.

Entities:  

Mesh:

Year:  2006        PMID: 16549332     DOI: 10.1016/j.bpg.2005.11.003

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  18 in total

1.  Long mesentericoportal vein resection and end-to-end anastomosis without graft in pancreaticoduodenectomy.

Authors:  Ji Zhang; Hong-Gang Qian; Jia-Hua Leng; Ming Cui; Hui Qiu; Guo-Quan Zhou; Jian-Hui Wu; Yong Yang; Chun-Yi Hao
Journal:  J Gastrointest Surg       Date:  2008-12-11       Impact factor: 3.452

2.  Assessment of hepatic arterial anatomy in keeping with preservation of the vasculature while performing pancreatoduodenectomy: an opinion.

Authors:  Sung Hoon Yang; Yong Hu Yin; Jin-Young Jang; Seung Eun Lee; Jin Wook Chung; Kyung-Suk Suh; Kuhn Uk Lee; Sun-Whe Kim
Journal:  World J Surg       Date:  2007-12       Impact factor: 3.352

Review 3.  Borderline resectable pancreatic cancer.

Authors:  Bhargava Mullapudi; Patrick J Hawkes; Asish Patel; Chandrakanth Are; Subhasis Misra
Journal:  Indian J Surg Oncol       Date:  2015-01-04

4.  Posterior Superior Mesenteric Artery (SMA) First Approach vs. Standard Pancreaticoduodenectomy in Patients with Resectable Periampullary Cancers: a Prospective Comparison Focusing on Circumferential Resection Margins.

Authors:  Sujoy Pal; Joseph George; Anand Narayan Singh; Sandeep Mathur; Nihar Ranjan Dash; Pramod Garg; Peush Sahni; T K Chattopadhyay
Journal:  J Gastrointest Cancer       Date:  2018-09

5.  Is there a role for arterial reconstruction in surgery for pancreatic cancer?

Authors:  Reena Ravikumar; David Holroyd; Giuseppe Fusai
Journal:  World J Gastrointest Surg       Date:  2013-03-27

6.  Racial disparities in treatment for pancreatic cancer and impact on survival: a population-based analysis.

Authors:  Vinamrata Singal; Ashwani K Singal; Yong-Fang Kuo
Journal:  J Cancer Res Clin Oncol       Date:  2012-01-15       Impact factor: 4.553

7.  Dissecting racial disparities in the treatment of patients with locoregional pancreatic cancer: a 2-step process.

Authors:  Taylor S Riall; Courtney M Townsend; Yong-Fang Kuo; Jean L Freeman; James S Goodwin
Journal:  Cancer       Date:  2010-02-15       Impact factor: 6.860

8.  Impact of splenectomy on thrombocytopenia, chemotherapy, and survival in patients with unresectable pancreatic cancer.

Authors:  Timothy R Donahue; Kevork K Kazanjian; William H Isacoff; Howard A Reber; O Joe Hines
Journal:  J Gastrointest Surg       Date:  2010-03-23       Impact factor: 3.452

9.  Surgical resectability of pancreatic adenocarcinoma: CTA.

Authors:  Jimmie C Wong; Steven Raman
Journal:  Abdom Imaging       Date:  2009-05-26

10.  Conditionally replicative adenoviral vectors for imaging the effect of chemotherapy on pancreatic cancer cells.

Authors:  Jun Kimura; Hidetaka A Ono; Takashi Kosaka; Yoji Nagashima; Shuichi Hirai; Shigeo Ohno; Kazunori Aoki; Davydova Julia; Masato Yamamoto; Chikara Kunisaki; Itaru Endo
Journal:  Cancer Sci       Date:  2013-07-03       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.